UBS Group AG - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 48 filers reported holding ACUMEN PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$415
-96.7%
100
-96.8%
0.00%
Q1 2023$12,737
-52.8%
3,137
+16.7%
0.00%
Q3 2022$27,000
+28.6%
2,687
-48.8%
0.00%
Q1 2022$21,000
+250.0%
5,245
+512.0%
0.00%
Q4 2021$6,000
-33.3%
857
+40.5%
0.00%
Q3 2021$9,0006100.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders